Artac, M. Et Al. 2016. Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study. 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , (Copenhagen, Denmark).

Artac, M., Korkmaz, L., COŞKUN, H. Ş., DANE, F., KARABULUT, B., Karaagac, M., ... ÇABUK, D.(2016). Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study . 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark

Artac, M. Et Al. "Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study," 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 2016

Artac, M. Et Al. "Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark, 2016

Artac, M. Et Al. (2016) . "Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark.

@conferencepaper{conferencepaper, author={M. Artac Et Al. }, title={Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study}, congress name={41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Copenhagen}, country={Denmark}, year={2016}}